Used in biomedical research to quantify EGFL6 protein levels in cell lysates, tissue extracts, and biological fluids such as serum or plasma. Widely applied in studies related to angiogenesis, tumor development, and tissue remodeling. Supports research in cancer biology, particularly in ovarian, breast, and liver cancers where EGFL6 is overexpressed. Enables investigation of EGFL6’s role in endothelial cell proliferation and migration. Suitable for high-throughput screening in drug discovery and evaluation of therapeutic targets. Provides a reliable, sensitive, and specific method for monitoring changes in EGFL6 expression under experimental conditions.